CTNM
Contineum Therapeutics
$9.15
+$0.16 (+1.78%)Oct 28, 2026
Key metrics
The numbers that frame CTNM today
- Market cap
- $344.23M
- ROIC
- -27.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $6.73
- 52wk High
- $17.79
Growth
Revenue and earnings trend for CTNM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTNM
Is Contineum Therapeutics a good buy?
No. Contineum Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Contineum Therapeutics is selling at a very high price.
What is the market capitalization of CTNM?
Contineum Therapeutics's market capitalization is $344.23M.
What is the 52-week high for CTNM stock?
The 52-week high for Contineum Therapeutics is $17.79. The current close of $9.15 is 48.6% below that high.
What is the 52-week low for CTNM stock?
The 52-week low for Contineum Therapeutics is $6.73. The current close of $9.15 is 36.1% above that low.
Does CTNM stock pay dividends?
Contineum Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTNM?
Contineum Therapeutics's Debt / Equity ratio is 0.03.